SCHEMBL597315

SCHEMBL597315

N=C(N)c1ccc(OCCCCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.90
PLAU P00749 2/20 0.90
ST14 Q9Y5Y6 2/20 0.90
PRSS1 P07477 10/20 0.69
KLK1 P06870 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14599538 1.00 F2 (0.90) F2PLAUST14PRSS1KLK1
Dibrompropamidine SCHEMBL292947 0.95 F2 (1.00) F2PLAUST14PRSS1
Dibrompropamidine SCHEMBL29709297 0.95 F2 (1.00) F2PLAUST14PRSS1
Dibrompropamidine SCHEMBL21083095 0.93 F2 (0.97) F2PLAUST14PRSS1
SCHEMBL22824438 0.93 F2 (0.78) F2PLAUST14PRSS1KLK1
SCHEMBL1428334 0.93 F2 (0.78) F2PLAUST14PRSS1KLK1
Dibrompropamidine SCHEMBL28086367 0.88 F2 (0.85) F2PLAUST14PRSS1
SCHEMBL16360744 0.87 F2 (0.79) F2PLAUST14PRSS1
SCHEMBL16808202 0.85 F2 (0.67) F2PLAUST14PRSS1KLK1
SCHEMBL20528835 0.85 F2 (0.67) F2PLAUST14PRSS1KLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US claimed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US claimed
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565065-A1 A PRESERVATION METHOD AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565197-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4450128-A2 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2024-10-23 EP claimed
US-12076436-B2 Bacterial ferment of Lactobacillus species SYMRISE AG (DE) 2024-09-03 US claimed
EP-4392497-A1 INK APPLICATORS Inkbox Ink Incorporated (CA) 2024-07-03 EP claimed
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
WO-2024028267-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-08 WO claimed
US-20090263439-A1 Antimicrobial Preservative Free Wipe THE PROCTER & GAMBLE COMPANY (US) 2009-10-22 US claimed
US-7582681-B2 Synergistic mixtures of 1,2-alkane diols SYMRISE GMBH & CO. KG (DE) 2009-09-01 US claimed
WO-2009000097-A2 PRESERVATIVE-FREE COMPOSITIONS COMPRISING CINNAMIC OR ANISIC ACID AND A BENZALDEHYDE (DERIVATIVE) GIVAUDAN SA (CH) 2008-12-31 WO claimed
WO-2008129494-A1 ANTIMICROBIAL PRESERVATIVE FREE WIPE THE PROCTER & GAMBLE COMPANY (US) 2008-10-30 WO claimed
EP-1982689-A1 Antimicrobial preservative free wipe The Procter and Gamble Company (US) 2008-10-22 EP claimed
EP-1898952-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) Symrise GmbH & Co. KG (DE) 2008-03-19 EP claimed
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2007-03-08 US claimed
WO-2006134160-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2006-12-21 WO claimed
EP-1478231-B1 SYNERGISTIC MIXTURES OF 1,2-ALKANE DIOLS SYMRISE GMBH & CO KG (DE) 2006-08-30 EP claimed
US-20040001777-A1 Mold remediation system and method DH TECHNOLOGIES, LLP 2004-01-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA F2 960/4885PLAU 1032/4885ST14 2602/4885
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK F2 2806/4885PLAU 4289/4885ST14 4274/4885
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) NR1H3, NR1H2, CBR3 F2 1925/4885PLAU 4875/4885ST14 2690/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 F2 1731/4885PLAU 3922/4885ST14 2416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.